| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 7,774 | 19,708 | 4,633 | 11,137 | | Cost of Revenue | 6,736 | 17,146 | 3,897 | 15,524 | | | Gross Profit | 1,038 | 2,562 | 736 | (4,387) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,596 | 3,329 | 2,800 | 1,583 | | Non Recurring |
-
|
-
|
-
| 1,655 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,558) | (767) | (2,064) | (7,625) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28 | 77 | 47 | 410 | | Earnings Before Interest And Taxes | (1,530) | (690) | (2,017) | (7,215) | | Interest Expense | 880 | 818 | 808 | 838 | | Income Before Tax | (2,410) | (1,508) | (2,825) | (8,053) | | Income Tax Expense | (974) | (535) | (1,003) | (3,023) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,436) | (973) | (1,822) | (5,030) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,436) | (973) | (1,822) | (5,030) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,436) | ($973) | ($1,822) | ($5,030) |
|
0.18% Nasdaq 
0.69 (2.36%) 
Income Statement
